Stay updated on AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.

Latest updates to the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page
- Check2 days agoChange DetectedThe site footer’s revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov error page, announcing transition updates and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page remains a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedA 403 Forbidden error is now displayed on the study record page, making the detailed study content inaccessible. This change blocks access to the study's information and reflects an access-restriction rather than new data updates.SummaryDifference17%

- Check65 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a minor maintenance update to the ClinicalTrials.gov entry. This update does not reflect changes in the study data.SummaryDifference0.1%

Stay in the know with updates to AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.